Global Liver Biopsy Market is touted to grow at a CAGR of 4.2% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in a minutely analyzed research report.
Advancements in medical technology have presented new approaches to performing liver biopsy which is less invasive or non-invasive which spurs the growth of the global liver biopsy market.
By end user, the market has been segmented into hospitals & clinics, tertiary care centers, urology centers, and others.
The global liver biopsy market spans across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa.
Asia Pacific market is expected to expand at a relatively faster rate than others owing to the rapidly developing healthcare sector in the fast-developing countries such as India, Japan, and China coupled with high prevalence of liver disorders in the region.The Middle East & Africa market holds the least share of the global market.
Along with the diagnosis it is also used to monitor the effect of treatment and determine whether the kidney transplant is working well or not.
It consists of mainly two types; percutaneous biopsy, transjugular, and laparoscopic.
In a percutaneous biopsy, a needle is inserted into the kidney through the skin, while in the surgical biopsy, an incision is made in the skin near the liver to take a tissue sample for examination.Increasing prevalence of liver diseases and increasing number of biopsy procedures and diseases are the major drivers for the growth of the market.
Furthermore, rising demand for new techniques for diagnosis of chronic and the need for better diagnostic and treatment methods drive the growth of the market.
Major players in the developed countries lead the global market by offering new products and services to the developing countries and emerging economies.
However, the high cost of diagnostic devices and instruments may hinder the market growth during the forecast period.Get a free sample copy @ https://www.marketresearchfuture.com/sample_request/5534 Intended AudienceResearch and Development (R) CompaniesAmbulatory Care CentersAcademic Institutes and UniversitiesBiotechnology CompaniesMedical Device ManufacturersMedical Device SuppliersMarket Research and Consulting Service ProvidersPotential InvestorsSegmentations:The global liver biopsy market is segmented on the basis of type, indication, and end user.On the basis of diagnosis, it is segmented into percutaneous, transjugular, and laparoscopic biopsy.On the basis of indication, it is segmented into the nonalcoholic fatty liver disease, chronic hepatitis B or C, autoimmune hepatitis, alcoholic liver disease, and others.Based on the end user, it is segmented into hospitals & clinics, tertiary care centers, urology centers, and others.
Liver Biopsy Market Analysis By By type (Trans Jugular, Laparoscopic Biopsy), End User (Urology Centers, Clinics, Hospitals), By Indication (Chronic Hepatitis, Alcoholic Liver Disease), Competitive Landscape, Regional Analysis, Forecast To 2023
The global Liver Biopsy Market is touted to grow at a CAGR of 4.2% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in a minutely analyzed research report.
Advancements in medical technology have presented new approaches to performing liver biopsy which is less invasive or non-invasive which spurs the growth of the global liver biopsy market.
Conversely, the high cost of diagnostic devices is expected to hamper the growth of the global liver biopsy market over the forecast period.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/5534
The global liver biopsy market has been segmented based on
